文献速递消化系统肿瘤

谱系逆转驱动肠道肿瘤获得WNT非依赖性

Lineage Reversion Drives WNT Independence in Intestinal Cancer.
PubMed 文献 · Cancer Discov · 2020-06-16

该研究探讨结直肠癌中WNT抑制剂耐药机制,发现KRAS或BRAF突变联合TP53和SMAD4失活的肠上皮细胞,经短暂TGFβ暴露后发生YAP/TAZ依赖性转录重编程和谱系逆转。细胞获得胚胎肠身份并永久失去成体肠谱系,实现长期WNT非依赖性生长,从而对WNT抑制产生耐药。

要点

  • WNT抑制在多数结直肠癌模型中阻断生长,但相关基因突变积累可致耐药。
  • KRAS/BRAF突变联合TP53/SMAD4失活加短暂TGFβ暴露驱动谱系逆转。
  • 谱系逆转经YAP/TAZ依赖重编程实现永久WNT非依赖性生长。

核心结论

  • WNT抑制在多数结直肠癌类器官和体内模型中阻断肿瘤生长,但相关基因突变的积累使细胞获得耐药和WNT非依赖性生长能力。

研究设计与样本

  • 研究使用结直肠癌类器官和体内模型,探讨WNT抑制后的耐药机制。

主要发现

  • 在携带KRAS或BRAF突变且TP53和SMAD4失活的肠上皮细胞中,短暂TGFβ暴露驱动YAP/TAZ依赖性转录重编程和谱系逆转。
  • 细胞获得胚胎肠身份,伴随成体肠谱系的永久丧失和长期WNT非依赖性生长。

临床怎么用

  • 研究提示联合靶向YAP/TAZ或其他相关通路可能克服WNT抑制剂获得性耐药,但需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The WNT pathway is a fundamental regulator of intestinal homeostasis, and hyperactivation of WNT signaling is the major oncogenic driver in colorectal cancer. To date, there are no described mechanisms that bypass WNT dependence in intestinal tumors. Here, we show that although WNT suppression blocks tumor growth in most organoid and in vivo colorectal cancer models, the accumulation of colorectal cancer-associated genetic alterations enables drug resistance and WNT-independent growth. In intestinal epithelial cells harboring mutations in KRAS or BRAF, together with disruption of TP53 and SMAD4, transient TGFβ exposure drives YAP/TAZ-dependent transcriptional reprogramming and lineage reversion. Acquisition of embryonic intestinal identity is accompanied by a permanent loss of adult intestinal lineages, and long-term WNT-independent growth. This work identifies genetic and microenvironmental factors that drive WNT inhibitor resistance, defines a new mechanism for WNT-independent colorectal cancer growth, and reveals how integration of associated genetic alterations and extracellular signals can overcome lineage-dependent oncogenic programs. SIGNIFICANCE: Colorectal and intestinal cancers are driven by mutations in the WNT pathway, and drugs aimed at suppressing WNT signaling are in active clinical development. Our study identifies a mechanism of acquired resistance to WNT inhibition and highlights a potential strategy to target those drug-resistant cells.This article is highlighted in the In This Issue feature, p. 1426.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Han T, Goswami S, Hu Y, et al. Lineage Reversion Drives WNT Independence in Intestinal Cancer. Cancer Discov. 2020. PMID: 32546576. doi:10.1158/2159-8290.CD-19-1536

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。